Global Non-invasive Neuromodulation Device Sales Market Report 2021

1 Non-invasive Neuromodulation Device Market Overview

• 1.1 Non-invasive Neuromodulation Device Product Scope
• 1.2 Non-invasive Neuromodulation Device Segment by Type
  • 1.2.1 Global Non-invasive Neuromodulation Device Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Transcranial Direct Current Stimulation (tDCS)
  • 1.2.3 Transcranial Alternating Current Stimulation (tACS)
  • 1.2.4 Transcranial Pulsed Current Stimulation (tPCS)
  • 1.2.5 Transcranial Random Noise Stimulation (tRNS)
  • 1.2.6 Electroconvulsive therapy (ECT)
  • 1.2.7 Others
• 1.3 Non-invasive Neuromodulation Device Segment by Application
  • 1.3.1 Global Non-invasive Neuromodulation Device Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Non-invasive Neuromodulation Device Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Non-invasive Neuromodulation Device Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Non-invasive Neuromodulation Device Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Non-invasive Neuromodulation Device Price Trends (2016-2027)

2 Non-invasive Neuromodulation Device Estimates and Forecasts by Region

• 2.1 Global Non-invasive Neuromodulation Device Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Non-invasive Neuromodulation Device Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Non-invasive Neuromodulation Device Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Non-invasive Neuromodulation Device Revenue Market Share by Region (2016-2021)
• 2.3 Global Non-invasive Neuromodulation Device Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Non-invasive Neuromodulation Device Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Non-invasive Neuromodulation Device Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Non-invasive Neuromodulation Device Estimates and Projections (2016-2027)
  • 2.4.2 Europe Non-invasive Neuromodulation Device Estimates and Projections (2016-2027)
  • 2.4.3 China Non-invasive Neuromodulation Device Estimates and Projections (2016-2027)
  • 2.4.4 Japan Non-invasive Neuromodulation Device Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Non-invasive Neuromodulation Device Estimates and Projections (2016-2027)
  • 2.4.6 India Non-invasive Neuromodulation Device Estimates and Projections (2016-2027)

3 Global Non-invasive Neuromodulation Device Competition Landscape by Players

• 3.1 Global Top Non-invasive Neuromodulation Device Players by Sales (2016-2021)
• 3.2 Global Top Non-invasive Neuromodulation Device Players by Revenue (2016-2021)
• 3.3 Global Non-invasive Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-invasive Neuromodulation Device as of 2020)
• 3.4 Global Non-invasive Neuromodulation Device Average Price by Company (2016-2021)
• 3.5 Manufacturers Non-invasive Neuromodulation Device Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Non-invasive Neuromodulation Device Market Size by Type

• 4.1 Global Non-invasive Neuromodulation Device Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Non-invasive Neuromodulation Device Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Non-invasive Neuromodulation Device Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Non-invasive Neuromodulation Device Price by Type (2016-2021)
• 4.2 Global Non-invasive Neuromodulation Device Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Non-invasive Neuromodulation Device Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Non-invasive Neuromodulation Device Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Non-invasive Neuromodulation Device Price Forecast by Type (2022-2027)

5 Global Non-invasive Neuromodulation Device Market Size by Application

• 5.1 Global Non-invasive Neuromodulation Device Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Non-invasive Neuromodulation Device Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Non-invasive Neuromodulation Device Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Non-invasive Neuromodulation Device Price by Application (2016-2021)
• 5.2 Global Non-invasive Neuromodulation Device Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Non-invasive Neuromodulation Device Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Non-invasive Neuromodulation Device Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Non-invasive Neuromodulation Device Price Forecast by Application (2022-2027)

6 North America Non-invasive Neuromodulation Device Market Facts & Figures

• 6.1 North America Non-invasive Neuromodulation Device Sales by Company
  • 6.1.1 North America Non-invasive Neuromodulation Device Sales by Company (2016-2021)
  • 6.1.2 North America Non-invasive Neuromodulation Device Revenue by Company (2016-2021)
• 6.2 North America Non-invasive Neuromodulation Device Sales Breakdown by Type
  • 6.2.1 North America Non-invasive Neuromodulation Device Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Non-invasive Neuromodulation Device Sales Breakdown by Type (2022-2027)
• 6.3 North America Non-invasive Neuromodulation Device Sales Breakdown by Application
  • 6.3.1 North America Non-invasive Neuromodulation Device Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Non-invasive Neuromodulation Device Sales Breakdown by Application (2022-2027)

7 Europe Non-invasive Neuromodulation Device Market Facts & Figures

• 7.1 Europe Non-invasive Neuromodulation Device Sales by Company
  • 7.1.1 Europe Non-invasive Neuromodulation Device Sales by Company (2016-2021)
  • 7.1.2 Europe Non-invasive Neuromodulation Device Revenue by Company (2016-2021)
• 7.2 Europe Non-invasive Neuromodulation Device Sales Breakdown by Type
  • 7.2.1 Europe Non-invasive Neuromodulation Device Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Non-invasive Neuromodulation Device Sales Breakdown by Type (2022-2027)
• 7.3 Europe Non-invasive Neuromodulation Device Sales Breakdown by Application
  • 7.3.1 Europe 144 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 144 Sales Breakdown by Application (2022-2027)

8 China Non-invasive Neuromodulation Device Market Facts & Figures

• 8.1 China Non-invasive Neuromodulation Device Sales by Company
  • 8.1.1 China Non-invasive Neuromodulation Device Sales by Company (2016-2021)
  • 8.1.2 China Non-invasive Neuromodulation Device Revenue by Company (2016-2021)
• 8.2 China Non-invasive Neuromodulation Device Sales Breakdown by Type
  • 8.2.1 China Non-invasive Neuromodulation Device Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Non-invasive Neuromodulation Device Sales Breakdown by Type (2022-2027)
• 8.3 China Non-invasive Neuromodulation Device Sales Breakdown by Application
  • 8.3.1 China 313 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 313 Sales Breakdown by Application (2022-2027)

9 Japan Non-invasive Neuromodulation Device Market Facts & Figures

• 9.1 Japan Non-invasive Neuromodulation Device Sales by Company
  • 9.1.1 Japan Non-invasive Neuromodulation Device Sales by Company (2016-2021)
  • 9.1.2 Japan Non-invasive Neuromodulation Device Revenue by Company (2016-2021)
• 9.2 Japan Non-invasive Neuromodulation Device Sales Breakdown by Type
  • 9.2.1 Japan Non-invasive Neuromodulation Device Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Non-invasive Neuromodulation Device Sales Breakdown by Type (2022-2027)
• 9.3 Japan Non-invasive Neuromodulation Device Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Non-invasive Neuromodulation Device Market Facts & Figures

• 10.1 Southeast Asia Non-invasive Neuromodulation Device Sales by Company
  • 10.1.1 Southeast Asia Non-invasive Neuromodulation Device Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Non-invasive Neuromodulation Device Revenue by Company (2016-2021)
• 10.2 Southeast Asia Non-invasive Neuromodulation Device Sales Breakdown by Type
  • 10.2.1 Southeast Asia Non-invasive Neuromodulation Device Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Non-invasive Neuromodulation Device Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Non-invasive Neuromodulation Device Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Non-invasive Neuromodulation Device Market Facts & Figures

• 11.1 India Non-invasive Neuromodulation Device Sales by Company
  • 11.1.1 India Non-invasive Neuromodulation Device Sales by Company (2016-2021)
  • 11.1.2 India Non-invasive Neuromodulation Device Revenue by Company (2016-2021)
• 11.2 India Non-invasive Neuromodulation Device Sales Breakdown by Type
  • 11.2.1 India Non-invasive Neuromodulation Device Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Non-invasive Neuromodulation Device Sales Breakdown by Type (2022-2027)
• 11.3 India Non-invasive Neuromodulation Device Sales Breakdown by Application
  • 11.3.1 India Non-invasive Neuromodulation Device Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Non-invasive Neuromodulation Device Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Non-invasive Neuromodulation Device Business

• 12.1 Neuroelectrics
  • 12.1.1 Neuroelectrics Corporation Information
  • 12.1.2 Neuroelectrics Business Overview
  • 12.1.3 Neuroelectrics Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Neuroelectrics Non-invasive Neuromodulation Device Products Offered
  • 12.1.5 Neuroelectrics Recent Development
• 12.2 Magstim
  • 12.2.1 Magstim Corporation Information
  • 12.2.2 Magstim Business Overview
  • 12.2.3 Magstim Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Magstim Non-invasive Neuromodulation Device Products Offered
  • 12.2.5 Magstim Recent Development
• 12.3 NeuroCare Group
  • 12.3.1 NeuroCare Group Corporation Information
  • 12.3.2 NeuroCare Group Business Overview
  • 12.3.3 NeuroCare Group Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 NeuroCare Group Non-invasive Neuromodulation Device Products Offered
  • 12.3.5 NeuroCare Group Recent Development
• 12.4 Soterix Medical
  • 12.4.1 Soterix Medical Corporation Information
  • 12.4.2 Soterix Medical Business Overview
  • 12.4.3 Soterix Medical Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Soterix Medical Non-invasive Neuromodulation Device Products Offered
  • 12.4.5 Soterix Medical Recent Development
• 12.5 Newronika
  • 12.5.1 Newronika Corporation Information
  • 12.5.2 Newronika Business Overview
  • 12.5.3 Newronika Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Newronika Non-invasive Neuromodulation Device Products Offered
  • 12.5.5 Newronika Recent Development
• 12.6 Rogue Resolutions
  • 12.6.1 Rogue Resolutions Corporation Information
  • 12.6.2 Rogue Resolutions Business Overview
  • 12.6.3 Rogue Resolutions Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Rogue Resolutions Non-invasive Neuromodulation Device Products Offered
  • 12.6.5 Rogue Resolutions Recent Development
• 12.7 Medtronic
  • 12.7.1 Medtronic Corporation Information
  • 12.7.2 Medtronic Business Overview
  • 12.7.3 Medtronic Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Medtronic Non-invasive Neuromodulation Device Products Offered
  • 12.7.5 Medtronic Recent Development
• 12.8 Philips Healthcare
  • 12.8.1 Philips Healthcare Corporation Information
  • 12.8.2 Philips Healthcare Business Overview
  • 12.8.3 Philips Healthcare Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Philips Healthcare Non-invasive Neuromodulation Device Products Offered
  • 12.8.5 Philips Healthcare Recent Development
• 12.9 Shenzhen Yingchi Technology
  • 12.9.1 Shenzhen Yingchi Technology Corporation Information
  • 12.9.2 Shenzhen Yingchi Technology Business Overview
  • 12.9.3 Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Products Offered
  • 12.9.5 Shenzhen Yingchi Technology Recent Development
• 12.10 Shenzhen Hanix United
  • 12.10.1 Shenzhen Hanix United Corporation Information
  • 12.10.2 Shenzhen Hanix United Business Overview
  • 12.10.3 Shenzhen Hanix United Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Shenzhen Hanix United Non-invasive Neuromodulation Device Products Offered
  • 12.10.5 Shenzhen Hanix United Recent Development
• 12.11 Shanghai Qiankang Medical Care Company
  • 12.11.1 Shanghai Qiankang Medical Care Company Corporation Information
  • 12.11.2 Shanghai Qiankang Medical Care Company Business Overview
  • 12.11.3 Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Products Offered
  • 12.11.5 Shanghai Qiankang Medical Care Company Recent Development
• 12.12 TCT Research
  • 12.12.1 TCT Research Corporation Information
  • 12.12.2 TCT Research Business Overview
  • 12.12.3 TCT Research Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 TCT Research Non-invasive Neuromodulation Device Products Offered
  • 12.12.5 TCT Research Recent Development
• 12.13 EB Neuro SpA
  • 12.13.1 EB Neuro SpA Corporation Information
  • 12.13.2 EB Neuro SpA Business Overview
  • 12.13.3 EB Neuro SpA Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2016-2021)
  • 12.13.4 EB Neuro SpA Non-invasive Neuromodulation Device Products Offered
  • 12.13.5 EB Neuro SpA Recent Development

13 Non-invasive Neuromodulation Device Manufacturing Cost Analysis

• 13.1 Non-invasive Neuromodulation Device Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Non-invasive Neuromodulation Device
• 13.4 Non-invasive Neuromodulation Device Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Non-invasive Neuromodulation Device Distributors List
• 14.3 Non-invasive Neuromodulation Device Customers

15 Market Dynamics

• 15.1 Non-invasive Neuromodulation Device Market Trends
• 15.2 Non-invasive Neuromodulation Device Drivers
• 15.3 Non-invasive Neuromodulation Device Market Challenges
• 15.4 Non-invasive Neuromodulation Device Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List